Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial von Patel, Manish R, Ellerton, John, Infante, Jeffrey R, Agrawal, Manish, Gordon, Michael, Aljumaily, Raid, Britten, Carolyn D, Dirix, Luc, Lee, Keun-Wook, Taylor, Mathew, Schöffski, Patrick, Wang, Ding, Ravaud, Alain, Gelb, Arnold B, Xiong, Junyuan, Rosen, Galit, Gulley, James L, Apolo, Andrea B

Volltext

The Challenge and Opportunity of NTRK Inhibitors in Non-Small Cell Lung Cancer von Qin, Haixia, Patel, Manish R

Volltext

Anticancer potential of rhizome extract and a labdane diterpenoid from Curcuma mutabilis plant endemic to Western Ghats of India von Soumya, T., Lakshmipriya, T., Klika, Karel D., Jayasree, P. R., Manish Kumar, P. R.

Volltext

A Comprehensive Safety Assessment of Algae Protein from Picochlorum for Human Consumption von Dattaroy, Tomal, Shukla, Manish R

Volltext

CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial von Oki, Yasuhiro, Kelly, Kevin R, Flinn, Ian, Patel, Manish R, Gharavi, Robert, Ma, Anna, Parker, Jefferson, Hafeez, Amir, Tuck, David, Younes, Anas

Volltext

Targeting PI3 kinase in cancer von Bauer, Todd M, Patel, Manish R, Infante, Jeffrey R

Volltext

JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models von Patel, Manish R., Dash, Alexander, Jacobson, Blake A., Ji, Yan, Baumann, Daniel, Ismail, Kareem, Kratzke, Robert A.

Volltext

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study von Apolo, Andrea B, Infante, Jeffrey R, Balmanoukian, Ani, Patel, Manish R, Wang, Ding, Kelly, Karen, Mega, Anthony E, Britten, Carolyn D, Ravaud, Alain, Mita, Alain C, Safran, Howard, Stinchcombe, Thomas E, Srdanov, Marko, Gelb, Arnold B, Schlichting, Michael, Chin, Kevin, Gulley, James L

Volltext

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors von Luke, Jason J, Lemons, Jeffrey M, Karrison, Theodore G, Pitroda, Sean P, Melotek, James M, Zha, Yuanyuan, Al-Hallaq, Hania A, Arina, Ainhoa, Khodarev, Nikolai N, Janisch, Linda, Chang, Paul, Patel, Jyoti D, Fleming, Gini F, Moroney, John, Sharma, Manish R, White, Julia R, Ratain, Mark J, Gajewski, Thomas F, Weichselbaum, Ralph R, Chmura, Steven J

Volltext

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma von Pectasides, Eirini, Stachler, Matthew D, Derks, Sarah, Liu, Yang, Maron, Steven, Islam, Mirazul, Alpert, Lindsay, Kwak, Heewon, Kindler, Hedy, Polite, Blase, Sharma, Manish R, Allen, Kenisha, O'Day, Emily, Lomnicki, Samantha, Maranto, Melissa, Kanteti, Rajani, Fitzpatrick, Carrie, Weber, Christopher, Setia, Namrata, Xiao, Shu-Yuan, Hart, John, Nagy, Rebecca J, Kim, Kyoung-Mee, Choi, Min-Gew, Min, Byung-Hoon, Nason, Katie S, O'Keefe, Lea, Watanabe, Masayuki, Baba, Hideo, Lanman, Rick, Agoston, Agoston T, Oh, David J, Dunford, Andrew, Thorner, Aaron R, Ducar, Matthew D, Wollison, Bruce M, Coleman, Haley A, Ji, Yuan, Posner, Mitchell C, Roggin, Kevin, Turaga, Kiran, Chang, Paul, Hogarth, Kyle, Siddiqui, Uzma, Gelrud, Andres, Ha, Gavin, Freeman, Samuel S, Rhoades, Justin, Reed, Sarah, Gydush, Greg, Rotem, Denisse, Davison, Jon, Imamura, Yu, Adalsteinsson, Viktor, Lee, Jeeyun, Bass, Adam J, Catenacci, Daniel V

Volltext

Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple my... von Younes, Anas, Dr, Berdeja, Jesus G, MD, Patel, Manish R, MD, Flinn, Ian, MD, Gerecitano, John F, MD, Neelapu, Sattva S, MD, Kelly, Kevin R, MD, Copeland, Amanda R, MSN, Akins, Amy, BSN, Clancy, Myles S, MBA, Gong, Lucy, PharmD, Wang, Jing, PhD, Ma, Anna, MS, Viner, Jaye L, MD, Oki, Yasuhiro, MD

Volltext

Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response von Sidders, Ben, Zhang, Pei, Goodwin, Kelly, O'Connor, Greg, Russell, Deanna L, Borodovsky, Alexandra, Armenia, Joshua, McEwen, Robert, Linghu, Bolan, Bendell, Johanna C, Bauer, Todd M, Patel, Manish R, Falchook, Gerald S, Merchant, Melinda, Pouliot, Gayle, Barrett, J Carl, Dry, Jonathan R, Woessner, Rich, Sachsenmeier, Kris

Volltext

A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors von Falchook, Gerald, Patnaik, Amita, Richardson, Debra L., Harvey, R. Donald, Sharma, Manish R., Hafez, Navid, Hamilton, Erika, Piha-Paul, Sarina A., Barve, Minal, Wise-Draper, Trisha, Patel, Manish R., Dowlati, Afshin, Pascuzzo, Joseph, Tang, Shou-Ching, Faltermeier, Christina, Malinowska, Izabela A., Shtessel, Luda, Striha, Alina, Potocka, Elizabeth

Volltext

Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1... von Palanca-Wessels, Maria Corinna A, Dr, Czuczman, Myron, Prof, Salles, Gilles, Prof, Assouline, Sarit, MD, Sehn, Laurie H, MD, Flinn, Ian, MD, Patel, Manish R, MD, Sangha, Randeep, MD, Hagenbeek, Anton, MD, Advani, Ranjana, MD, Tilly, Herve, Prof, Casasnovas, Olivier, MD, Press, Oliver W, Prof, Yalamanchili, Sreeni, PharmD, Kahn, Robert, MD, Dere, Randall C, BSc, Lu, Dan, PhD, Jones, Surai, MS, Jones, Cheryl, ScD, Chu, Yu-Waye, MD, Morschhauser, Franck, Prof

Volltext

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia von Issa, Ghayas C., Aldoss, Ibrahim, DiPersio, John, Cuglievan, Branko, Stone, Richard, Arellano, Martha, Thirman, Michael J., Patel, Manish R., Dickens, David S., Shenoy, Shalini, Shukla, Neerav, Kantarjian, Hagop, Armstrong, Scott A., Perner, Florian, Perry, Jennifer A., Rosen, Galit, Bagley, Rebecca G., Meyers, Michael L., Ordentlich, Peter, Gu, Yu, Kumar, Vinit, Smith, Steven, McGeehan, Gerard M., Stein, Eytan M.

Volltext

Climatological features of rapidly intensifying tropical cyclones in the North Indian Ocean von Ranalkar, Manish R., Giri, Ram Kumar, Ray, Kamaljit

Volltext

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors von Demetri, George D, De Braud, Filippo, Drilon, Alexander, Siena, Salvatore, Patel, Manish R, Cho, Byoung Chul, Liu, Stephen V, Ahn, Myung-Ju, Chiu, Chao-Hua, Lin, Jessica J, Goto, Koichi, Lee, Jeeyun, Bazhenova, Lyudmila, John, Thomas, Fakih, Marwan, Chawla, Sant P, Dziadziuszko, Rafal, Seto, Takashi, Heinzmann, Sebastian, Pitcher, Bethany, Chen, David, Wilson, Timothy R, Rolfo, Christian

Volltext

Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients von Sullivan, Ryan J., Hamid, Omid, Gonzalez, Rene, Infante, Jeffrey R., Patel, Manish R., Hodi, F. Stephen, Lewis, Karl D., Tawbi, Hussein A., Hernandez, Genevive, Wongchenko, Matthew J., Chang, YiMeng, Roberts, Louise, Ballinger, Marcus, Yan, Yibing, Cha, Edward, Hwu, Patrick

Volltext

Surface Warming During the 2018/Mars Year 34 Global Dust Storm von Streeter, Paul M., Lewis, Stephen R., Patel, Manish R., Holmes, James A., Kass, David M.

Volltext

First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors von Falchook, Gerald, Infante, Jeffrey, Arkenau, Hendrik-Tobias, Patel, Manish R., Dean, Emma, Borazanci, Erkut, Brenner, Andrew, Cook, Natalie, Lopez, Juanita, Pant, Shubham, Frankel, Arthur, Schmid, Peter, Moore, Kathleen, McCulloch, William, Grimmer, Katharine, O'Farrell, Marie, Kemble, George, Burris, Howard

Volltext